All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Semaglutide 0.25mg: Missed Dose

Missed a dose of semaglutide 0.25mg? Learn what to do, how missed doses affect your treatment, and how to get back on schedule safely.

By FormBlends Editorial Research|Source reviewed by FormBlends Medical Team||

Source Reviewed

Written by FormBlends Editorial Research · Checked against primary sources by FormBlends Medical Team

Semaglutide 0.25mg: Missed Dose custom 2026 header image for GLP-1 Weight Loss
Custom header image for Semaglutide 0.25mg: Missed Dose, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: Semaglutide 0.25mg: Missed Dose

Missed a dose of semaglutide 0.25mg? Learn what to do, how missed doses affect your treatment, and how to get back on schedule safely.

Short answer

Missed a dose of semaglutide 0.25mg? Learn what to do, how missed doses affect your treatment, and how to get back on schedule safely.

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide, cash price and coverage terms

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

See your GLP-1 options in about 2 minutes. Free and private. See my options →

Missed a dose of semaglutide 0.25mg? Learn what to do, how missed doses affect your treatment, and how to get back on schedule safely.

Life happens. Travel, a busy week, or simply forgetting your injection day can all lead to a missed dose of semaglutide. If you're at the 0.25mg introductory dose and you have missed a scheduled injection, you aren't alone, and there are clear steps you can follow.

We put together this guide based on the prescribing information and clinical guidance to help you understand what to do when you miss a dose, how it affects your treatment, and how to prevent it from happening again. Your physician is always the best resource for personalized advice, but this information will help you respond quickly and confidently.

The General Guidance for a Missed Dose

According to the prescribing information for semaglutide, the approach to a missed dose depends on how much time has passed since your scheduled injection:

If It Has Been 5 Days or Fewer Since Your Missed Dose

Take the missed dose as soon as possible. Then resume your regular weekly schedule. For example, if your normal injection day is Monday and you remember on Thursday, take the injection on Thursday and continue with Monday the following week.

If It Has Been More Than 5 Days Since Your Missed Dose

Skip the missed dose entirely. Wait until your next regularly scheduled injection day and take your normal dose at that time. Don't double up by taking two doses to make up for the missed one.

This five-day threshold is important because semaglutide has a half-life of approximately one week. Taking a dose too close to your next scheduled injection could result in overlapping drug levels that increase the risk of side effects, particularly GI symptoms.

How a Missed Dose Affects Your Body

Knowing what happens pharmacologically when you miss a dose can help put your mind at ease:

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Semaglutide 0.25mg: Missed Dose

Drug Levels Decline Gradually

Because semaglutide has a long half-life, a single missed dose doesn't mean the drug disappears from your system immediately. After your last injection, levels decline gradually over the following days. You may still have some medication activity for several days after your scheduled dose was due. For a complete cost breakdown, see our compare GLP-1 providers.

Appetite May Return Partially

As drug levels drop, you may notice a temporary increase in appetite or a return of cravings that had diminished. This is normal and typically resolves once you take your next dose. At 0.25mg, these changes may be subtle since the appetite effects at this introductory dose are already mild for many patients.

GI Symptoms Are Unlikely to Worsen

Missing a dose generally doesn't cause GI side effects. In fact, patients who were experiencing mild nausea or digestive changes may notice temporary relief during the gap. When you resume, there's a small chance of GI symptoms returning briefly, similar to what you experienced with your first injection.

One Missed Dose Is Not a Setback

A single missed dose at the 0.25mg level is unlikely to significantly affect your overall treatment trajectory. The introductory phase is about building tolerance, and one missed week doesn't undo the adaptation your body has already made.

What If You Miss Multiple Doses?

If you miss two or more consecutive doses, the situation changes. Extended gaps in treatment mean that semaglutide levels in your body have dropped significantly or cleared entirely. In this case:

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →
  • Contact your physician. They will advise whether you should resume at 0.25mg or whether any adjustments to your plan are needed.
  • Your physician may recommend restarting the titration. If you have been off the medication for several weeks, your body may have lost the GI adaptation it gained during your initial weeks of treatment. Restarting at 0.25mg helps prevent a surge of side effects.
  • Don't jump to a higher dose. Even if your physician had planned to escalate you, resuming after an extended gap should start at the introductory dose unless your physician specifically directs otherwise.

Clinical Trial Context: Dosing Consistency

The STEP clinical trials emphasized consistent weekly dosing throughout the treatment period. The dose-escalation schedule used in the trials was:

  • Weeks 1 through 4: 0.25mg once weekly
  • Weeks 5 through 8: 0.5mg once weekly
  • Weeks 9 through 12: 1.0mg once weekly
  • Weeks 13 through 16: 1.7mg once weekly
  • Week 17 onward: 2.4mg once weekly

Adherence to the weekly schedule was important for achieving the trial outcomes. While a single missed dose is manageable, consistent adherence produces the best results.

How Titration Is Affected by Missed Doses

If you miss a dose during the 0.25mg phase, it may extend the time before your physician recommends moving to 0.5mg. This is because:

  • Semaglutide takes approximately four to five weeks of consistent dosing to reach steady-state levels at any given dose. A missed dose delays reaching steady state.
  • Your physician wants to evaluate your tolerance based on consistent exposure. If you missed a week, the data from that period is less reliable for making dosing decisions.
  • Extending the 0.25mg phase by a week or two to account for a missed dose is a conservative but reasonable approach.

Discuss any missed doses with your physician so they can factor this into your escalation timeline.

Preventing Missed Doses

Consistency is one of the most important factors in successful GLP-1 therapy. Here are practical strategies to help you stay on schedule:

  • Set a recurring alarm. Choose a specific day and time each week and set a phone reminder.
  • Link it to a routine. Pair your injection with a weekly habit you already have, such as a specific meal or activity.
  • Keep your medication visible. Store your pen (per the storage requirements) in a place where you'll see it on injection day.
  • Use a tracking app or calendar. Mark each injection on a calendar or use a medication tracking app to maintain a visual record.
  • Travel planning. If you're traveling, pack your medication in your carry-on and adjust your injection time for time zone changes. Consult your physician about travel considerations.
  • Have a backup plan. If your regular injection day falls on a busy or unusual day, decide in advance when you'll take it instead.

Safety Reminders

  • Never take a double dose. Taking two doses in one week to "catch up" increases the risk of severe nausea, vomiting, and other side effects.
  • Don't change your dose without physician approval. Even if you feel fine, dose changes should be managed by your provider.
  • Monitor for unusual symptoms when resuming. After a missed dose, pay attention to how you feel when you resume. While most patients tolerate the restart well, report any concerns to your physician.
  • Stay hydrated. As always, adequate hydration supports GI tolerance and overall health during treatment.
  • Remember the contraindications. Semaglutide isn't appropriate for patients with a personal or family history of medullary thyroid carcinoma or MEN 2.

Frequently Asked Questions

I missed my dose by two days. Should I take it now or wait?

If it has been five days or fewer since your scheduled injection, take the missed dose as soon as you remember. Then continue with your regular weekly schedule. If more than five days have passed, skip the dose and take your next one on schedule.

Will missing one dose undo my progress?

No. A single missed dose at 0.25mg won't significantly impact your overall treatment. Semaglutide's long half-life means some drug activity continues for days after a missed injection. Resume your schedule and continue as planned.

Should I restart from week one if I missed a dose?

For a single missed dose, restarting the titration is generally not necessary. If you have missed two or more consecutive doses, contact your physician. They may recommend restarting at 0.25mg depending on how long the gap was.

Can I change my injection day?

Yes, you can change your injection day as long as your last dose was at least two days (48 hours) prior. After selecting your new day, maintain that schedule going forward. Discuss any changes with your physician.

What if I keep forgetting my doses?

If missed doses are becoming a pattern, talk with your physician. Adherence is critical for treatment success. Your care team can help you troubleshoot barriers and find strategies that work for your lifestyle.

Stay on Track With FormBlends Support

At FormBlends, our care team is available to help you manage your treatment schedule and answer questions when unexpected situations arise. We build personalized plans and provide ongoing support so you can stay consistent and get the most out of your GLP-1 therapy.

Need help getting back on schedule? Reach out to your FormBlends physician or schedule a consultation today.

Disclaimer: This content is for educational purposes only and doesn't constitute medical advice, diagnosis, or treatment. Always consult your physician or qualified healthcare provider before starting, stopping, or changing any medication. Individual results vary. Semaglutide is a prescription medication and should only be used under the supervision of a licensed healthcare provider.

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
Retatrutide evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Semaglutide 0.25mg: Missed Dose, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Randomized trialSemaglutide evidence2021

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.

PubMed

Randomized trialSemaglutide evidence2021

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance

Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.

PubMed

Randomized trialSemaglutide evidence2022

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight

Supports head-to-head context when pages compare older and newer GLP-1 options.

PubMed

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Emerging pharmacotherapies for obesity: A systematic review

Broad context for new and established obesity-drug categories.

PubMed

ReviewObesity pharmacotherapy evidence2026

Glucagon-like receptor agonists and next-generation incretin-based medications

Current review for incretin-based obesity medications and cardiometabolic effects.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

Used as a class-level evidence anchor when no more specific citation group matches.

PubMed

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Direct answer

Semaglutide 0.25mg: Missed Dose research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

Missed a dose of semaglutide 0.25mg? Learn what to do, how missed doses affect your treatment, and how to get back on schedule safely. Read "Semaglutide 0.25mg: Missed Dose" as a GLP-1 treatment guide where medication choice, dosing, side effects, monitoring, and insurance rules can change the decision. The main job of this page is dosing literacy and clinician follow-up, especially where the topic touches semaglutide, dosing. Because this article has 9 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. Use it to ask sharper questions of a licensed clinician, not as a substitute for personal medical advice.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Semaglutide 0.25mg

For this glp-1 weight loss page, the 2026 refresh focuses on semaglutide, tirzepatide, retatrutide, cash-pay pricing, safety signals, 25mg so the article stays close to the question behind "Semaglutide 0.25mg".

The useful details are the practical ones: what to verify, what changes risk or cost, and which details separate Semaglutide 0.25mg from nearby GLP-1, peptide, hormone, or provider-comparison searches.

Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision.

Semaglutide 0.25mg custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for Semaglutide 0.25mg, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering Semaglutide 0.25mg, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research. Claims are checked against primary regulatory, trial, label, and public-health sources where available. Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.